Particle
.news
Insmed, Inc.
Biotech corporation
3 ARTICLES
last wk.
Liquidia Reports 900+ Yutrepia Prescriptions in 11 Weeks, Targets Profitability Within 3–4 Quarters
Management highlights payer contracts alongside a high early fill rate to underline launch momentum.
9 ARTICLES
last mo.
FDA Approves Brensocatib as First Treatment for Non-Cystic Fibrosis Bronchiectasis